Target intelligence / Profile preview

UBX domain-containing protein 2B (UBXN2B)

Target
UBXN2B
Molecular classification
Other, Ubiquitin regulatory X (UBX) domain family protein, Adapter protein
01

Overview

UBX domain-containing protein 2B (UBXN2B) is an adapter protein belonging to the ubiquitin regulatory X (UBX) domain family. It is primarily involved in the **maintenance and biogenesis of the Golgi apparatus and endoplasmic reticulum during the cell cycle**, playing key roles in membrane fusion and reassembly at the end of mitosis. UBXN2B functions as a **cofactor for p97/VCP (an ATPase involved in diverse cellular functions including protein degradation)**, assisting in the regulation of protein homeostasis. It also participates in **regulating mitotic spindle orientation and centrosomal protein localization**, especially influencing the removal of Aurora kinase A from centrosomes during prophase. Diseases associated with alterations or mutations in UBXN2B include **inclusion body myopathy with early-onset Paget disease of bone with or without frontotemporal dementia and Brown-Séquard syndrome**. Although the UBX domain protein family is implicated in several cancers, UBXN2B itself does not have well-characterized roles as a direct disease driver or therapeutic target, nor are there any drugs or clinical biomarkers known to target or utilize UBXN2B in therapeutic contexts as of the latest data.

Other names
p37NSFL1 cofactor p37p97 cofactor p37UBX domain protein 2BUBXN2B
02

Biological functions

Ubiquitin binding activityAdapter/cofactor for membrane fusion (Golgi and endoplasmic reticulum biogenesis and reassembly)Regulation of mitotic spindle orientationNegative regulation of protein localization to centrosomePositive regulation of mitotic centrosome separationRegulation of Aurora kinase A (AURKA) levels at centrosomes during mitosisGolgi and endoplasmic reticulum maintenanceActivity in cytosol, nucleus, Golgi apparatus, endoplasmic reticulum, spindle pole centrosomeRegulation of p97/VCP activities (involved in protein degradation and homeostasis)
03

Disease associations

Inclusion body myopathy with early-onset Paget disease of bone with or without frontotemporal dementia 1Brown-Séquard syndromePossible roles in cancer via the UBXD (UBXN) family, but no direct evidence for UBXN2B specifically in cancer

Beyond the preview

Go deeper on UBX domain-containing protein 2B (UBXN2B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UBX domain-containing protein 2B (UBXN2B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call